Label-free multispectral fluorescence lifetime imaging enables non-invasive diagnosis of Alzheimer’s disease in cerebral organoids
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Optical Imaging and Spectroscopy Techniques · Advanced Fluorescence Microscopy Techniques · Optical Coherence Tomography Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Tau and amyloid-β in Alzheimer's disease: a new era for neurodegenerative disease drug development10.1038/s41591-023-02505-2 ↗
2. A century of Alzheimer's disease10.1126/science.1132814 ↗
3. Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides10.1073/pnas.1201632109 ↗
4. Animal models of Alzheimer's disease and frontotemporal dementia10.1038/nrn2420 ↗
5. Single-cell detection of secreted Aβ and sAPPα from human IPSC-derived neurons and astrocytes10.1523/JNEUROSCI.2735-15.2016 ↗
6. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons10.1038/cddis.2015.72 ↗
7. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes10.1038/nm0198-097 ↗
8. Lessons from a failed γ-secretase Alzheimer trial10.1016/j.cell.2014.10.016 ↗
9. Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings10.1185/03007995.2014.939167 ↗
10. Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes10.1371/journal.pone.0161969 ↗
11. Modeling Alzheimer's disease using induced pluripotent stem cells10.1515/revneuro-2020-0065 ↗
12. Disease-specific induced pluripotent stem cells10.1016/j.cell.2008.07.041 ↗
13. The promise of induced pluripotent stem cells in research and therapy10.1038/nature10761 ↗
14. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure10.1016/j.cell.2016.04.032 ↗
15. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals10.1016/j.stem.2008.09.002 ↗
16. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development10.1073/pnas.1520760112 ↗
17. Induction of expansion and folding in human cerebral organoids10.1016/j.stem.2016.11.017 ↗
18. A three-dimensional human neural cell culture model of Alzheimer's disease10.1038/nature13800 ↗
19. Modeling Alzheimer's disease with iPSC-derived brain cells10.1038/s41380-019-0468-3 ↗
20. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease10.1073/pnas.1317918110 ↗
21. Evaluating cell metabolism through autofluorescence imaging of NAD (P) H and FAD10.1089/ars.2017.7451 ↗
22. NAD (P) H autofluorescence lifetime imaging enables single cell analyses of cellular metabolism of osteoblasts in vitro and in vivo via two-photon microscopy10.1016/j.bone.2021.116257 ↗
23. Role of the extracellular matrix in Alzheimer’s disease10.3389/fnagi.2021.707466 ↗
24. Extracellular matrix proteins involved in Alzheimer's disease10.1002/chem.202000782 ↗
25. Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications10.1038/s43586-024-00358-8 ↗
26. Multi-wavelength fluorescence lifetime spectroscopy: a new approach to the study of endogenous fluorescence in living cells and tissues10.1002/lapl.200810132 ↗
27. Bridging the gap between invention and commercialization in medical devices10.1038/nbt.3041 ↗
28. Targeting IκB kinase β in adipocyte lineage cells for treatment of obesity and metabolic dysfunctions10.1002/stem.2358 ↗
29. Human adult neurogenesis: evidence and remaining questions10.1016/j.stem.2018.04.004 ↗
30. Tbr1 regulates differentiation of the preplate and layer 610.1016/S0896-6273(01)00211-2 ↗
31. Relaxed selection is a precursor to the evolution of phenotypic plasticity10.1073/pnas.1104825108 ↗
32. Uncertainty during anticipation modulates neural responses to aversion in human insula and amygdala10.1093/cercor/bhp155 ↗
33. Depletion of Trp53 and Cdkn2a does not promote self-renewal in the mammary gland but amplifies proliferation induced by TNF-α10.1016/j.stemcr.2020.12.012 ↗
34. The promises and challenges of human brain organoids as models of neuropsychiatric disease10.1038/nm.4214 ↗
35. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques10.1186/s40478-020-01075-5 ↗
36. Optical imaging using endogenous contrast to assess metabolic state10.1146/annurev-bioeng-071811-150108 ↗
37. Analog mean-delay method for high-speed fluorescence lifetime measurement10.1364/OE.17.002834 ↗
38. Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics10.1007/s11033-023-09021-z ↗
39. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease10.1016/j.bbadis.2013.10.015 ↗
40. Oxidative stress and the amyloid beta peptide in Alzheimer's disease10.1016/j.redox.2017.10.014 ↗
41. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques10.1186/s40478-020-01075-5 ↗
42. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease10.1007/s004010000195 ↗
43. Early changes in extracellular matrix in Alzheimer's disease10.1111/nan.12295 ↗
44. Electrophysiological analysis of brain organoids: current approaches and advancements10.3389/fnins.2020.622137 ↗
45. Identification of prognostic model and biomarkers for cancer stem cell characteristics in glioblastoma by network analysis of multi-omics data and stemness indices10.3389/fcell.2020.558961 ↗
46. Electrophysiological insights with brain organoid models: a brief review10.5483/BMBRep.2024-0077 ↗
47. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup10.1002/alz.13859 ↗
48. The clinical use of structural MRI in Alzheimer disease10.1038/nrneurol.2009.215 ↗
49. Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup10.2967/jnumed.124.268756 ↗
50. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease
51. Blood-based biomarkers of Alzheimer's disease and incident dementia in the community
52. Clinical performance of the fully automated Lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia
53. Lumbar puncture: considerations, procedure, and complications10.47936/encephalitis.2022.00045 ↗
54. Fluorescence lifetime imaging microscopy for the assessment of cellular metabolism: a review10.1007/s13206-022-00067-y ↗
55. Cerebral organoids model human brain development and microcephaly10.1038/nature12517 ↗
56. Fluorescence lifetime imaging – techniques and applications10.1111/j.1365-2818.2012.03618.x ↗
57. Fluorescence lifetime standards for time and frequency domain fluorescence spectroscopy10.1021/ac062160k ↗
58. Real-time visualization of two-photon fluorescence lifetime imaging microscopy using a wavelength-tunable femtosecond pulsed laser10.1364/BOE.9.003449 ↗
59. Separating NADH and NADPH fluorescence in live cells and tissues using FLIM10.1038/ncomms4936 ↗
60. Simultaneous NAD(P)H and FAD fluorescence lifetime microscopy of long UVA–induced metabolic stress in reconstructed human skin10.1038/s41598-021-00126-8 ↗
61. Separating NADH and NADPH fluorescence in live cells and tissues using FLIM, Nat. Commun. 5(1), 3936, 2014; T.P.L. Ung et al., Simultaneous NAD(P)H and FAD fluorescence lifetime microscopy of long UVA–induced metabolic stress in reconstructed human skin
62. Familial Alzheimer’s disease mutations in PSEN1 lead to premature human stem cell neurogenesis10.1016/j.celrep.2020.108615 ↗
63. Modeling Alzheimer’s disease with iPSC-derived brain cells10.1038/s41380-019-0468-3 ↗
64. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells10.1038/nature10821 ↗